nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethobenzamide—Coma—Aminophylline—chronic obstructive pulmonary disease	0.0459	0.0508	CcSEcCtD
Trimethobenzamide—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.0408	0.0451	CcSEcCtD
Trimethobenzamide—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.0317	0.035	CcSEcCtD
Trimethobenzamide—Bevantolol—ADRB2—chronic obstructive pulmonary disease	0.0316	0.33	CrCbGaD
Trimethobenzamide—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.0304	0.0336	CcSEcCtD
Trimethobenzamide—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.025	0.0276	CcSEcCtD
Trimethobenzamide—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.025	0.0276	CcSEcCtD
Trimethobenzamide—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.0245	0.0271	CcSEcCtD
Trimethobenzamide—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.0236	0.0261	CcSEcCtD
Trimethobenzamide—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.021	0.0232	CcSEcCtD
Trimethobenzamide—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.0204	0.0226	CcSEcCtD
Trimethobenzamide—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.0202	0.0223	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.0198	0.0219	CcSEcCtD
Trimethobenzamide—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.0197	0.0218	CcSEcCtD
Trimethobenzamide—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.0195	0.0216	CcSEcCtD
Trimethobenzamide—Cisapride—CYP1A2—chronic obstructive pulmonary disease	0.0191	0.2	CrCbGaD
Trimethobenzamide—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.019	0.021	CcSEcCtD
Trimethobenzamide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0184	0.0203	CcSEcCtD
Trimethobenzamide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.0178	0.0197	CcSEcCtD
Trimethobenzamide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0168	0.0186	CcSEcCtD
Trimethobenzamide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.0168	0.0185	CcSEcCtD
Trimethobenzamide—Cisapride—HTR2A—chronic obstructive pulmonary disease	0.0162	0.169	CrCbGaD
Trimethobenzamide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.0161	0.0178	CcSEcCtD
Trimethobenzamide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.0161	0.0178	CcSEcCtD
Trimethobenzamide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.0157	0.0174	CcSEcCtD
Trimethobenzamide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.0152	0.0168	CcSEcCtD
Trimethobenzamide—Verapamil—SLC6A4—chronic obstructive pulmonary disease	0.0151	0.158	CrCbGaD
Trimethobenzamide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.0142	0.0157	CcSEcCtD
Trimethobenzamide—Verapamil—CYP1A2—chronic obstructive pulmonary disease	0.0138	0.144	CrCbGaD
Trimethobenzamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.0132	0.0146	CcSEcCtD
Trimethobenzamide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.0127	0.0141	CcSEcCtD
Trimethobenzamide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.0127	0.0141	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.0125	0.0138	CcSEcCtD
Trimethobenzamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.0123	0.0136	CcSEcCtD
Trimethobenzamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.0121	0.0134	CcSEcCtD
Trimethobenzamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.0121	0.0134	CcSEcCtD
Trimethobenzamide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.012	0.0133	CcSEcCtD
Trimethobenzamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.0119	0.0131	CcSEcCtD
Trimethobenzamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0119	0.0131	CcSEcCtD
Trimethobenzamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.0115	0.0127	CcSEcCtD
Trimethobenzamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0112	0.0124	CcSEcCtD
Trimethobenzamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0112	0.0124	CcSEcCtD
Trimethobenzamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.0106	0.0117	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.0101	0.0111	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.0101	0.0111	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00985	0.0109	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00949	0.0105	CcSEcCtD
Trimethobenzamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00934	0.0103	CcSEcCtD
Trimethobenzamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00934	0.0103	CcSEcCtD
Trimethobenzamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00914	0.0101	CcSEcCtD
Trimethobenzamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00902	0.00998	CcSEcCtD
Trimethobenzamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00902	0.00998	CcSEcCtD
Trimethobenzamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00884	0.00977	CcSEcCtD
Trimethobenzamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00881	0.00975	CcSEcCtD
Trimethobenzamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00855	0.00945	CcSEcCtD
Trimethobenzamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.00855	0.00945	CcSEcCtD
Trimethobenzamide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00853	0.00944	CcSEcCtD
Trimethobenzamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00852	0.00942	CcSEcCtD
Trimethobenzamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00837	0.00926	CcSEcCtD
Trimethobenzamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00807	0.00893	CcSEcCtD
Trimethobenzamide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00784	0.00868	CcSEcCtD
Trimethobenzamide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.0062	0.00686	CcSEcCtD
Trimethobenzamide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.0057	0.0063	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00544	0.00602	CcSEcCtD
Trimethobenzamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00489	0.0054	CcSEcCtD
Trimethobenzamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00463	0.00512	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00396	0.00438	CcSEcCtD
Trimethobenzamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00367	0.00406	CcSEcCtD
Trimethobenzamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00355	0.00393	CcSEcCtD
Trimethobenzamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.00336	0.00372	CcSEcCtD
